NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $202,348 | -51.2% | 2,230 | -54.5% | 0.02% | -46.5% |
| Q2 2022 | $415,000 | -3.5% | 4,904 | +0.1% | 0.04% | +10.3% |
| Q1 2022 | $430,000 | -3.2% | 4,898 | -3.6% | 0.04% | +18.2% |
| Q4 2021 | $444,000 | +6.7% | 5,081 | -0.1% | 0.03% | -2.9% |
| Q3 2021 | $416,000 | -10.7% | 5,086 | -0.5% | 0.03% | -12.8% |
| Q2 2021 | $466,000 | +11.5% | 5,111 | +4.5% | 0.04% | +2.6% |
| Q1 2021 | $418,000 | -12.4% | 4,889 | -3.2% | 0.04% | -19.1% |
| Q4 2020 | $477,000 | -1.2% | 5,051 | -9.1% | 0.05% | -13.0% |
| Q3 2020 | $483,000 | +1.0% | 5,554 | +1.5% | 0.05% | -5.3% |
| Q2 2020 | $478,000 | +4.4% | 5,473 | -1.5% | 0.06% | -10.9% |
| Q1 2020 | $458,000 | -54.7% | 5,556 | -47.9% | 0.06% | +20.8% |
| Q4 2019 | $1,010,000 | +240.1% | 10,671 | +212.6% | 0.05% | +32.5% |
| Q3 2019 | $297,000 | – | 3,414 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |